HempMedsPX Seeks to Support Organizations Similar to Hope4Harper’s Mission to Spearhead Research Through the University of Pennsylvania
SAN DIEGO, Oct. 30, 2013 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to inform shareholders and the general public that HempMedsPX™ – a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. and Medical Marijuana, Inc. – that HempMedsPX™ recently presented a donation to augment the non-profit organization Hope4Harper‘s mission to fund CDKL5 epilepsy and seizure research through Dr. Frances Jensen, Chair of the Department of Neurology at the University of Pennsylvania. “We are honored to support medical research focused on easing the suffering of people with debilitating ailments,” states Michelle Sides, COO of Medical Marijuana, Inc.
A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=21803
With no known cure, CDKL5 is a rare genetic seizure disorder that typically presents itself in the first few months of a child’s life. Many with CDKL5 are not able to talk, walk, feed themselves, are confined to a wheelchair and suffer from an array of health issues. Penny Howard founded Hope4Harper for her daughter, Harper, who was diagnosed with CDKL5 at the age of ten months. While Penny and her husband are open to all mediums of therapy for three-year-old Harper, the Howards decided to add Real Scientific Hemp Oil™ (RSHO™) to Harper’s daily routine and is sharing her results on a weekly blog at Hope4Harper.com.
Charles Vest, VP of Communications for HempMedsPX™ states, “Providing financial assistance to 501(c)3 charities is part of our mission that includes helping as many families as possible gain access to the products that HempMedsPX™ represents. We have seen too many cases in the recent news about families and non-profit organizations working through the complex legal system to access medical cannabis-based CBD for their children with debilitating conditions. Hope4Harper is the perfect example of an organization that HempMedsPX™ wishes to support.”
“An interesting fact is that much like vitamin C is derived from various forms of citrus trees, CBD is derived from various forms of cannabis. We are extremely proud that the industrial hemp-based CBD products we represent are available to ship to all 50 states and are winning industry awards for highest hemp-based CBD concentration. We are elated to see that results from highly respected testing laboratories like Steep Hill Halent prove this,” concludes Vest.
- for people of all ages
- for animals
- legally in all 50 states and in more than 40 countries
- through dispensary and non-dispensary outlets
HempMedsPX™ represented the winner of the world-renowned 2013 High Times Cannabis Cup award and 2013 Michigan Medical Marijuana Conference “Green Cup” contests for Highest (hemp) CBD Concentrate.
For organizations seeking CBD for the individuals and families that they support, contact HempMedsPX for details.
HempMedsPX offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMedsPX is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the exclusive master distributor and contracted marketing company for CannaVest Corp. (OTC:CANV) and Medical Marijuana Inc. In addition to handling sales and distribution, HempMedsPX is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com
About CannaVest Corp.
CannaVest Corp. is in the business of investing and developing hemp-based cannabinoid companies. CannaVest Corp. also develops, produces, markets and sells end-consumer products to the nutraceutical industry containing the hemp plant extract, cannabidiol (CBD). Additionally, the company resells – to third parties – raw product acquired by CannaVest Corp. pursuant to the company’s international supply relationships. CannaVest Corp. seeks to take advantage of an emerging worldwide trend to re-energize the production of industrial hemp and to foster its many uses for consumers. Cannabinoids (cannabidiol/CBD) are natural constituents of the hemp plant, and CBD is derived from hemp stalk and seed. Additional information is available from OTCMarkets.com or by visiting CannaVest.com.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana, Inc., CannaVest Corp., and HempMedsPX do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell and distribute hemp-based products and are involved with Federally Legal Distribution of Medical Marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.
For further information, please contact:
Investor relations contact:
Stuart T. Smith